Mapping blood vessels and tumor spread in breast cancer
Part of Cancer clinical trials.
This study uses a special imaging technique called VTM to map blood vessels around the tumor, look at how far the cancer has spread, and check for similar spots elsewhere in the body. It is designed for women newly diagnosed with breast cancer who have not yet started any cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with breast cancer but have not yet started treatment.
- You are not pregnant or breastfeeding.
- You are not currently in another clinical trial or receiving cancer therapy (radiation, chemo, or surgery).
- You do not have a fever or skin condition that could interfere with the exam.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who are being screened and just diagnosed with breast cancer and haven’t started treatment yet. It may help researchers understand how to better manage care from the start of treatment.
This trial looks at tumor cells in the blood of women with breast cancer to understand them better. It may help doctors learn more about how the disease spreads.
This study looks at tiny particles released by cells (called extracellular vesicles) in people with breast cancer. It may help researchers better understand breast cancer and how it behaves, which could improve future testing or treatments.
This study is testing whether a special MRI scan can help show tiny features inside breast tumors (TMEM). It’s mainly a “feasibility” study, meaning the team is checking if the scan can be done safely and clearly in different types of operable breast cancer.
This trial tests a new Feminai device that maps breast tissue to find suspicious lumps. If you're coming for a routine mammogram or a biopsy, this could help improve detection.
This trial uses a special blood test to track cancer signals (called ctDNA) during and after treatment for early breast cancer. It aims to see whether monitoring these signals can help guide follow-up and treatment decisions.
Hear when a new Breast Cancer Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.